콘텐츠로 건너뛰기
Merck

855777P

Avanti

20:0 Lyso PC

Avanti Research - A Croda Brand

동의어(들):

1-eicosanoyl-sn-glycero-3-phosphocholine; PC(20:0/0:0)

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경

제품정보 (DICE 배송 시 비용 별도)

실험식(Hill 표기법):
C28H58NO7P
CAS 번호:
Molecular Weight:
551.74
MDL number:
UNSPSC Code:
51191904
NACRES:
NA.25
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의


제품 이름

20:0 Lyso PC, 1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine, powder

assay

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

form

powder

packaging

pkg of 1 × 200 mg (855777P-200mg), pkg of 1 × 25 mg (855777P-25mg)

manufacturer/tradename

Avanti Research - A Croda Brand 855777P

shipped in

dry ice

storage temp.

−20°C

SMILES string

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCCCCCC)=O

InChI

1S/C28H58NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-28(31)34-25-27(30)26-36-37(32,33)35-24-23-29(2,3)4/h27,30H,5-26H2,1-4H3/t27-/m1/s1

InChI key

UATOAILWGVYRQS-HHHXNRCGSA-N

Application

20:0 Lyso PC has been used as an internal standard for the quantification of serum cholesterol and triacylglycerol using liquid chromatography-mass spectrometry (LC-MS) preceded by single-step liquid-liquid extraction method.

Packaging

5 mL Amber Glass Screw Cap Vial (855777P-200mg)
5 mL Amber Glass Screw Cap Vial (855777P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


Still not finding the right product?

Explore all of our products under


저장 등급

11 - Combustible Solids



가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 문서 section.

도움이 필요하시면 연락하세요. 고객 지원 부서

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문



Serum lipidome analysis of healthy beagle dogs receiving different diets
Boretti FS, et al.
Metabolomics, 16(1), 1-1 (2020)
Kelsey B Law et al.
Autophagy, 13(5), 868-884 (2017-05-20)
Peroxisome biogenesis disorders (PBDs) are metabolic disorders caused by the loss of peroxisomes. The majority of PBDs result from mutation in one of 3 genes that encode for the peroxisomal AAA ATPase complex (AAA-complex) required for cycling PEX5 for peroxisomal